Identification of amidated forms of GLP-1 in rat tissues using a highly sensitive radioimmunoassay

Regulatory Peptides

Volumn 70, Issue 2-3, 1997, Pages 191-198

  Van Delft, Jozef ^a   Uttenthal, L O ^a   Hermida, O G ^b   Fontela, Tomás ^b   Ghiglione, Margarita ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

Author keywords

Antibody; Glucagon like immunoreactivity; Glucagon like peptide 1; Immunoreactive glucagon; Oxyntomodulin

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; OXYNTOMODULIN;

AMIDATION; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CROSS REACTION; DRUG RECEPTOR BINDING; HORMONAL REGULATION; IMMUNOREACTIVITY; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; RADIOIMMUNOASSAY; RAT; RECEPTOR AFFINITY;

ANIMALS; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-LIKE PEPTIDES; GLUCOSE; HYPOTHALAMUS; ILEUM; IMMUNE SERA; INTUBATION, GASTROINTESTINAL; MALE; ORGAN SPECIFICITY; PANCREAS; PEPTIDE FRAGMENTS; PEPTIDES; RABBITS; RADIOIMMUNOASSAY; RATS; RATS, WISTAR;

ANIMALIA; BOVINAE; ORYCTOLAGUS CUNICULUS;

EID: 0030792006     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(97)01009-4     Document Type: Article

References (19)

1. Ørskov C, Jeppesen J, Madsbad S, Holst JJ. Proglucagon products in plasma of non-insulin dependent diabetics and non-diabetic controls in the fasting state and following oral glucose and intravenous arginine. J Clin Invest 1990;87:415-23.
2. Ørskov C, Holst JJ. Radioimmunoassays for glucagon-like peptides-1 and -2 (GLP-1 and GLP-2). Scand J Clin Lab Invest 1987;47:165-74.
3. Kreymann B, Ghatei MA, Williams G, Bloom SR. Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet 1987;ii:1300-3.
4. Mentlein R, Gallwitz B, Schmidt WE. Dipeptidyl peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum. Eur J Biochem 1993;214:829-35.
5. O'Shaughnessy DJ. Antibodies. In: Bloom SR, Long RG, editors. Radioimmunoassay of Gut Regulatory Peptides. London: W.B. Saunders, 1982:11-20.
6. Uttenthal LO, Blázquez E. Characterization of high-affinity receptors for truncated glucagon-like peptide-1 in rat gastric glands. FEBS Lett 1990;262:139-41.
7. Adrian TE. Measurement in plasma. In: Bloom SR, Long RG, editors. Radioimmunoassay of Gut Regulatory Peptides. London: WB. Saunders, 1982:28-35.
8. 125I-glucagon by anion exchange chromatography. Horm Metab Res 1972;4:223-4.
9. Bryant MG, Bloom SR. Measurement in tissue. In: Bloom SR, Long RG, editors. Radioimmunoassay of Gut Regulatory Peptides. London: W.B. Saunders, 1982:36-41.
10. Assam R, Slusher N. Structure/function and structure/immunoreactivity relationships of the glucagon molecule and related syn-thetic peptides. Diabetes 1972;21:843-55.
11. Patzelt C, Tager HS, Carroll RJ, Steiner DF. Identification and processing of proglucagon in pancreatic islets. Nature 1979;282:260-6.
12. Patzelt C, Schiltz E. Conversion of proglucagon in pancreatic alpha cells: the major endproducts are glucagon and a single peptide, the major proglucagon fragment, that contains two glucagon-like sequences. Proc Natl Acad Sci USA 1984;81:5007-11.
13. Kreymann B, Yiangou Y, Kanse S, Williams G, Ghatei MA, Bloom SR. Isolation and characterisation of GLP-1(7-36) amide from rat intestine: elevated levels in diabetic rats. FEBS Lett 1988;242:167-70.
14. Mojsov S, Kopczynski MG, Habener JF. Both amidated and non-amidated forms of glucagon-like peptide I are synthesized in the rat intestine and the pancreas. J Biol Chem 1990;265:8001-8.
15. George SK, Uttenthal LO, Ghiglione M, Bloom SR. Molecular forms of glucagon-like peptides in man. FEBS Lett 1985;192:275-8.
16. Elliott RM, Morgan LM, Tredger JA, Deacon S, Wright J, Marks V. Glucagon-like peptide-1(7-36) amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns. J Endocrinol 1993;138:159-66.
17. Herrmann C, Göke R, Richter G, Fehmann HC, Arnold R, Göke B. Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients. Digestion 1995;56:117-26.
18. Schirra J, Katschinski M, Weidmann C, Schafer T, Wank U, Arnold R, Göke B. Gastric emptying and release of incretin hormones after glucose ingestion in humans. J Clin Invest 1996;97:92-103.
19. Kolligs F, Fehmann HC, Göke R, Göke B. Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9-39) amide. Diabetes 1995;44:16-9.